79 related articles for article (PubMed ID: 25961786)
1. Chronic myelogenous leukemia in eastern Pennsylvania: an assessment of registry reporting.
Mertz KJ; Buchanich JM; Washington TL; Irvin-Barnwell EA; Woytowitz DV; Smith RE
J Registry Manag; 2015; 42(1):9-11. PubMed ID: 25961786
[TBL] [Abstract][Full Text] [Related]
2. Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study.
Foulon S; Cony-Makhoul P; Guerci-Bresler A; Delord M; Solary E; Monnereau A; Bonastre J; Tubert-Bitter P
Cancer Med; 2019 Jun; 8(6):3296-3304. PubMed ID: 31038849
[TBL] [Abstract][Full Text] [Related]
3. Estimation of CML incidence: disagreement between national cancer registry and health claims data system in Taiwan.
Chang CS; Lee K; Yang YH; Lin MT; Hsu CN
Leuk Res; 2011 May; 35(5):e53-4. PubMed ID: 21255835
[No Abstract] [Full Text] [Related]
4. Updated and expanded study of polycythemia vera and other myeloproliferative neoplasms in the tri-county area.
Buchanich JM; Mertz KJ; Washington TL; Logue JN; Marchetto D; Roda PI; Irvin-Barnwell E
J Registry Manag; 2014; 41(4):175-81. PubMed ID: 25803630
[TBL] [Abstract][Full Text] [Related]
5. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
[TBL] [Abstract][Full Text] [Related]
6. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of childhood chronic myelogenous leukemia with monitoring the BCR-ABL fusion gene expression in peripheral blood.
Horváth A; Baghiu MD; Pap Z; Bănescu C; Mărginean CO; Pávai Z
Rom J Morphol Embryol; 2011; 52(3):907-13. PubMed ID: 21892537
[TBL] [Abstract][Full Text] [Related]
8. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
9. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
Polednak AP
J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
[TBL] [Abstract][Full Text] [Related]
10. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
12. [Detection of phosphotyrosine in bcr-abl-positive cells with PY20 antibody and its clinical applications].
Zhu HH; Liu YR; Qin YZ; Chang Y; Li JL; Ruan GR; Jiang B; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):441-4. PubMed ID: 17147244
[TBL] [Abstract][Full Text] [Related]
13. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.
Gaidano G; Guerrasio A; Serra A; Rege-Cambrin G; Saglio G
Leukemia; 1994 Apr; 8 Suppl 1():S27-9. PubMed ID: 8152300
[TBL] [Abstract][Full Text] [Related]
15. [Bcr-Abl inhibition as molecular therapy approach in chronic myeloid leukemia].
Buchdunger E
Med Klin (Munich); 2002 Jan; 97 Suppl 1():2-6. PubMed ID: 11831067
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany.
Rohrbacher M; Berger U; Hochhaus A; Metzgeroth G; Adam K; Lahaye T; Saussele S; Müller MC; Hasford J; Heimpel H; Hehlmann R
Leukemia; 2009 Mar; 23(3):602-4. PubMed ID: 18784744
[No Abstract] [Full Text] [Related]
17. [Descriptive epidemiology of myeloid leukemia].
Matsuo K; Ito H
Nihon Rinsho; 2009 Oct; 67(10):1847-51. PubMed ID: 19860178
[TBL] [Abstract][Full Text] [Related]
18. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
Arpinati M; Tolomelli G; Bochicchio MT; Castagnetti F; Amabile M; Bandini G; Bonifazi F; Stanzani M; Rosti G; Martinelli G; Baccarani M
Biol Blood Marrow Transplant; 2013 May; 19(5):735-40. PubMed ID: 23333776
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
20. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
